$5.22
-0.14-2.61%
At close: May 15, 5:00 PM EST
$5.33
0.112.11%
After Hours: 4:03 PM EST
Passage Bio Inc Earnings Estimates
PASGNASDAQ
Earnings: Q1 2026 Earnings were released on Tue May 12th, before the market open
Passage Bio Earnings Estimates, EPS & Revenue | NASDAQ:PASG
Passage Bio (PASG) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-2.37 and quarterly revenue of N/A.
In the most recent quarter (Q1), Passage Bio reported EPS of $-2.36, beating estimates of $-2.87 by 0.18%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Passage Bio has averaged an EPS surprise of 0.41% and a revenue surprise of 0.00%.
Earnings Date
Aug 11
EPS Estimate
$-2.370
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Passage Bio Earnings History
Analyze the earnings history of Passage Bio using advanced sorting and filters.
Loading calendar...
Passage Bio (PASG) Earnings Per Share
The chart below shows Passage Bio's reported EPS compared to analyst estimates over recent quarters.
Passage Bio (PASG) Revenue
The chart below shows Passage Bio's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Passage Bio (NASDAQ:PASG) reporting earnings?
Passage Bio (PASG) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
What were the latest earnings per share (EPS) for Passage Bio (NASDAQ:PASG)?
The Actual EPS was $-2.36, which beat the estimate of $-2.87.
What were Passage Bio’s (NASDAQ:PASG) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
